Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Vizoovet** is a preservative-free veterinary ophthalmic lubricating solution containing a natural extract mixture of propolis, Aloe vera, and chamomile. It is applied to the ocular surface of animals, principally dogs, as supportive treatment for keratoconjunctivitis sicca and other ocular-surface disorders. In prospective canine studies, Vizoovet used alongside standard treatment improved clinical signs of keratoconjunctivitis sicca and was associated with shorter healing time after diamond-burr debridement of spontaneous chronic corneal epithelial defects. The product has no established single molecular target and acts primarily through local ocular-surface lubrication, hydration, and protective soothing effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vizoovet.